172 related articles for article (PubMed ID: 10199742)
1. Immunomodulatory functions of hyaluronate in the LEW-to-F344 model of chronic cardiac allograft rejection.
Knoflach A; Magee C; Denton MD; Kim KS; Buelow R; Hancock WW; Sayegh MH
Transplantation; 1999 Mar; 67(6):909-14. PubMed ID: 10199742
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulatory functions of low-molecular weight hyaluronate in an acute rat renal allograft rejection model.
Knoflach A; Azuma H; Magee C; Denton M; Murphy B; Iyengar A; Buelow R; Sayegh MH
J Am Soc Nephrol; 1999 May; 10(5):1059-66. PubMed ID: 10232693
[TBL] [Abstract][Full Text] [Related]
3. Synthetic MHC class I peptide prolongs cardiac survival and attenuates transplant arteriosclerosis in the Lewis-->Fischer 344 model of chronic allograft rejection.
Murphy B; Kim KS; Buelow R; Sayegh MH; Hancock WW
Transplantation; 1997 Jul; 64(1):14-9. PubMed ID: 9233694
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production.
Jiang H; Wynn C; Pan F; Ebbs A; Erickson LM; Kobayashi M
Transplantation; 2002 Jun; 73(11):1808-17. PubMed ID: 12085006
[TBL] [Abstract][Full Text] [Related]
5. Intrathymic tolerance in the Lewis-to-F344 chronic cardiac allograft rejection model.
Shin YT; Adams DH; Wyner LR; Akalin E; Sayegh MH; Karnovsky MJ
Transplantation; 1995 Jun; 59(12):1647-53. PubMed ID: 7604433
[TBL] [Abstract][Full Text] [Related]
6. T-cell costimulatory blockade in experimental chronic cardiac allograft rejection: effects of cyclosporine and donor antigen.
Chandraker A; Russell ME; Glysing-Jensen T; Willett TA; Sayegh MH
Transplantation; 1997 Apr; 63(8):1053-8. PubMed ID: 9133464
[TBL] [Abstract][Full Text] [Related]
7. Cardiac allograft atherosclerosis in the rat. The effect of histocompatibility factors, cyclosporine, and an angiotensin-converting enzyme inhibitor.
Paul LC; Davidoff A; Benediktsson H
Transplantation; 1994 Jun; 57(12):1767-72. PubMed ID: 7517077
[TBL] [Abstract][Full Text] [Related]
8. A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection.
Yuan X; Dong VM; Coito AJ; Waaga AM; Salama AD; Benjamin CD; Sayegh MH; Chandraker A
Transplantation; 2002 Jun; 73(11):1736-42. PubMed ID: 12084995
[TBL] [Abstract][Full Text] [Related]
9. How cyclosporine modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts.
Koskinen PK; Lemström KB; Häyry PJ
Am J Pathol; 1995 Apr; 146(4):972-80. PubMed ID: 7536397
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of endothelin-1 improves survival and vasculopathy in rat cardiac transplants treated with cyclosporine.
Simonson MS; Robinson AV; Schulak JA; Hricik DE
Transplantation; 2002 Apr; 73(7):1054-9. PubMed ID: 11965031
[TBL] [Abstract][Full Text] [Related]
11. The effect of acute rejection and cyclosporin A-treatment on induction of platelet-derived growth factor and its receptors during the development of chronic rat renal allograft rejection.
Savikko J; Kallio EA; Taskinen E; von Willebrand E
Transplantation; 2002 Feb; 73(4):506-11. PubMed ID: 11889420
[TBL] [Abstract][Full Text] [Related]
12. Blocking of CD44-hyaluronic acid interaction prolongs rat allograft survival.
Zhang W; Gao L; Qi S; Liu D; Xu D; Peng J; Daloze P; Chen H; Buelow R
Transplantation; 2000 Feb; 69(4):665-7. PubMed ID: 10708127
[TBL] [Abstract][Full Text] [Related]
13. Prolongation of allograft survival with viral IL-10 transfection in a highly histoincompatible model of rat heart allograft rejection.
Zuo Z; Wang C; Carpenter D; Okada Y; Nicolaidou E; Toyoda M; Trento A; Jordan SC
Transplantation; 2001 Mar; 71(5):686-91. PubMed ID: 11292303
[TBL] [Abstract][Full Text] [Related]
14. Sinomenine blocks tissue remodeling in a rat model of chronic cardiac allograft rejection.
Mark W; Schneeberger S; Seiler R; Stroka DM; Amberger A; Offner F; Candinas D; Margreiter R
Transplantation; 2003 Apr; 75(7):940-5. PubMed ID: 12698077
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory effects of the alkaloid sinomenine in the high responder ACI-to-Lewis cardiac allograft model.
Candinas D; Mark W; Kaever V; Miyatake T; Koyamada N; Hechenleitner P; Hancock WW
Transplantation; 1996 Dec; 62(12):1855-60. PubMed ID: 8990376
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine and skin allografts for the treatment of thermal injury. I. Extensive graft survival with low-level long-term administration and prolongation in a rat burn model.
Hewitt CW; Black KS; Aguinaldo AM; Achauer BM; Howard EB
Transplantation; 1988 Jan; 45(1):8-12. PubMed ID: 3276067
[TBL] [Abstract][Full Text] [Related]
17. Chronic rejection in experimental cardiac transplantation: studies in the Lewis-F344 model.
Adams DH; Russell ME; Hancock WW; Sayegh MH; Wyner LR; Karnovsky MJ
Immunol Rev; 1993 Aug; 134():5-19. PubMed ID: 8225375
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. I. Prolongation of rat cardiac and renal allograft survival by the PG27 extract and immunosuppressive synergy in combination therapy with cyclosporine.
Wang J; Xu R; Jin R; Chen Z; Fidler JM
Transplantation; 2000 Aug; 70(3):447-55. PubMed ID: 10949186
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model.
Poston RS; Billingham M; Hoyt EG; Pollard J; Shorthouse R; Morris RE; Robbins RC
Circulation; 1999 Jul; 100(1):67-74. PubMed ID: 10393683
[TBL] [Abstract][Full Text] [Related]
20. Exploitation of the continuum between early ischemia/reperfusion injury and host alloresponsiveness: indefinite kidney allograft survival by treatment with a soluble P-selectin ligand and low-dose cyclosporine in combination.
Kusaka M; Zandi-Nejad K; Kato S; Beato F; Nagano H; Shaw GD; Tilney NL
Transplantation; 1999 May; 67(9):1255-61. PubMed ID: 10342318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
